'Addicted' cells provide early cancer diagnosis

Jun 10, 2008

Scientists at the Institute of Food Research have detected subtle changes that may make the bowel more vulnerable to the development of tumours.

With support from the Food Standards Agency and the Biotechnology and Biological Sciences Research Council they are investigating whether diet could control these changes and delay or reverse the onset of cancer.

"We looked at changes in 18 genes that play a role in the very earliest stages of colorectal cancer," says Professor Ian Johnson at the Institute of Food Research.

"We detected clear chemical differences in these genes in otherwise normal tissue in cancer patients.

"This represents a new way to identify defects that could eventually lead to cancer."

All cells carry a complete set of instructions for the whole organism in their nuclear DNA, but to define the specialised structure and functions of each particular cell type, genes must be switched on or firmly off, over the course of the cell's life-cycle.

One of the mechanisms controlling the activities of the genes in a cell is the "epigenetic code", a set of chemical tags attached to the DNA molecule, marking individual genes for expression, or for silence. It is well known that the abnormal behaviour of cancer cells is partly due to mistakes in this epigenetic code, some of which switch on genes for growth, whilst others switch off genes that would otherwise cause abnormal cells to destroy themselves.

Scientists at IFR are exploring the possibility that such mistakes in the epigenetic code may begin to occur in apparently normal tissues, long before the appearance of a tumour.

In the current study published in the British Journal of Cancer they measured the numbers of methyl groups attached to DNA taken from the cells lining the large intestine of bowel cancer patients. They found subtle changes that may make the whole surface of the bowel more vulnerable to the eventual development of tumours by causing the 'addiction' of cells to abnormal gene expression.

Some of these changes seem to occur naturally with age, but, supported by the Food Standards Agency, IFR is investigating the possibility that factors in our lifestyle such as diet, obesity and exercise can accelerate or delay DNA methylation as we grow older, thus giving us some degree of control over this vital aspect of our long-term health.

Professor Nigel Brown, Director of Science and Technology at BBSRC said: "Basic research in the relatively young field of epigenetics is already contributing to our understanding of human health. Understanding how epigenetic processes work to maintain healthy cells and tissues is the key to long-term health because, as we see here, the breakdown of these normal processes may subsequently cause disease. BBSRC funds a range of research in the field of epigenetics and has been encouraging networking amongst members of the European epigenetics research community."

Source: Norwich BioScience Institutes

Explore further: Many throat cancer patients can skip neck surgery

add to favorites email to friend print save as pdf

Related Stories

Final pieces to the circadian clock puzzle found

Sep 14, 2014

Researchers at the UNC School of Medicine have discovered how two genes – Period and Cryptochrome – keep the circadian clocks in all human cells in time and in proper rhythm with the 24-hour day, as well ...

Team makes scientific history with new cellular connection

Sep 11, 2014

Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection. Their discovery has implications for diseases linked to mitochondria, ...

Recommended for you

Many throat cancer patients can skip neck surgery

10 minutes ago

A new study shows that patients with human papillomavirus (HPV) – the same virus associated with both cervical and head and neck cancer – positive oropharyngeal cancer see significantly higher rates of complete response ...

Five genes to predict colorectal cancer relapses

15 minutes ago

Researchers at the Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), led by David Garcia-Molleví have identified 5 genes differentially expressed in normal accompanying ...

User comments : 0